The researchers say that increases in the rate of infection could be mitigated through the development of a national strategy for Hepatitis B, which would increase awareness of the disease and encourage those infected to seek treatment.
Our cost-effectiveness analyses indicate investment in such a strategy is economically justified given the looming increase in the numbers of people infected and the drug therapies that are available to treat those infected, said Professor Butler.
Source-Medindia
GPL